Adia Nutrition (ADIA) Cash from Investing Activities (2025 - 2026)
Adia Nutrition's (ADIA) quarterly Cash from Investing Activities came in at -$5494.0 in Q1 2026, down 96.64% year-over-year from -$163300.4 in Q1 2025, and down 96.64% quarter-over-quarter from -$2794.0 in Q1 2025.
Powered by 
Analysis
Adia Nutrition (ADIA) Cash from Investing Activities (2025 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Cash from Investing Activities for 2 consecutive years, with -$5494.0 the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | -161.58 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | -55.66 Mn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | -74.05 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | -120.00 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 53.26 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 26.69 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | -9.88 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | -93.37 Mn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | -2.82 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |